Please note: In order to keep Hive up to date and provide users with the best features, we are no longer able to fully support Internet Explorer. The site is still available to you, however some sections of the site may appear broken. We would encourage you to move to a more modern browser like Firefox, Edge or Chrome in order to experience the site fully.

Handbook of Assay Development in Drug Discovery, Hardback Book

Handbook of Assay Development in Drug Discovery Hardback

Edited by Lisa K. (Johnson & Johnson Pharmaceutical Res & Dev, LLC, Springhouse, Pennsylvania, USA) Minor

Part of the Drug Discovery Series series

Hardback

Description

The need to screen targets faster and more efficiently, coupled with advances in parallel and multiplex chemical synthesis, has contributed to the increasing use of multiwell assays for drug discovery.

The Handbook of Assay Development in Drug Discovery is a reference that describes the complete armament of tools currently available for performing various assay techniques. Featuring contributions from assay developers in the pharmaceutical and vendor communities, the book presents descriptions of methods, laboratory guidelines and protocols used to perform such methods, specific examples of each assay system, and troubleshooting tools.

The handbook describes biochemical assay classes as well as non-class specific assay development for cell-based assays.

It covers a wide range of target classes—including kinases, proteases, nuclear receptors, and GPCRs—and describes currently employed methods and assay types, such as radioligand binding assays, image analysis assays, enzyme fragment complementation, and bioluminescent and fluorescent-based assays.

Designed as a guide to running an assay from start to finish, the Handbook of Assay Development in Drug Discovery is an ideal bench top companion for discovery researchers, laboratory managers, academics, and other scientists involved in drug discovery screening, lead profiling, therapeutic target evaluation, and assay development and implementation in the pharmaceutical and biotechnology industries.

Daniel E. Levy, editor of the Drug Discovery Series, is the founder of DEL BioPharma, a consulting service for drug discovery programs.

He also maintains a blog that explores organic chemistry.

Information

  • Format:Hardback
  • Pages:482 pages, 45 Tables, black and white; 21 Halftones, black and white; 226 Illustrations, black and w
  • Publisher:Taylor & Francis Inc
  • Publication Date:
  • Category:
  • ISBN:9781574444711

£200.00

 
Free Home Delivery

on all orders

 
Pick up orders

from local bookshops

Information

  • Format:Hardback
  • Pages:482 pages, 45 Tables, black and white; 21 Halftones, black and white; 226 Illustrations, black and w
  • Publisher:Taylor & Francis Inc
  • Publication Date:
  • Category:
  • ISBN:9781574444711